Provided is a formulation including a vitamin D3 compound and a corticosteroid as active ingredients, wherein the pharmaceutical composition for the skin has exceptional stability of each of the active ingredients and suitable percutaneous absorptivity of the active ingredients. The present invention provides a non-aqueous composition for the skin, wherein the composition contains (a) maxacalcitol, (b) at least one corticosteroid selected from the group consisting of betamethasone and esters thereof, (c) at least one low-polarity ester oil having an IOB value from 0.07 to less than 0.20, and (d) at least one non-polar liquid solvent.
